Pitot, Henry C. et al
"Phase I Dose-finding and Pharmacokinetic Trial of Irinotecan Hydrochloride (CPT-11) Using a Once-Every-Three-Week Dosing Schedule for Patients with Advanced Solid Tumor Malignancy." Clinical Cancer Research
6.6
(2000):
2236-2244.
Web. 03 Mar. 2021.
